Bio Path reported 0.65 in PE Price to Earnings for its fiscal quarter ending in March of 2025.





Pe Change Date
Baxter International 20.35 131.6 Sep/2026
Cipla 38.39 2.57 Sep/2026
Clal Biotechnology 11.67 2.62 Dec/2022
Compugen 5.58 0.12 Jun/2026
CSL 16.16 9.59 Dec/2025
Grifols 11.2 1.08 Dec/2025